abstract |
A Rho-related protein kinase (ROCK) inhibitor of formula (I), a pharmaceutical composition containing said Rho-related protein kinase inhibitor, methods for their preparation, and uses of the ROCK inhibitor for treating and preventing ROCK-mediated diseases are provided. |